MicroRNA-543 promotes the proliferation and invasion of clear cell renal cell carcinoma cells by targeting Krüppel-like factor 6.

[1]  H. Wen,et al.  PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  Jianhua Zhang,et al.  miR-543 promotes colorectal cancer proliferation and metastasis by targeting KLF4 , 2017, Oncotarget.

[3]  Shuo Yang,et al.  MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK , 2017, OncoTargets and therapy.

[4]  Lei Wang,et al.  MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP , 2017, Cellular Physiology and Biochemistry.

[5]  Jianjun He,et al.  miR-4262 Promotes Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting KLF6 and KLF15 , 2017, Oncology research.

[6]  Xin Ma,et al.  KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1. , 2017, Cancer research.

[7]  M. Dong,et al.  Dysregulation of MicroRNA‐543 expression in colorectal cancer promotes tumor migration and invasion , 2017, Molecular carcinogenesis.

[8]  G. Halmos,et al.  Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC. , 2016, Urologic oncology.

[9]  Tonghua Liu,et al.  miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression. , 2016, International journal of oncology.

[10]  C. Tu,et al.  miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation. , 2016, Oncology reports.

[11]  Wei Huang,et al.  MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein , 2016, Oncotarget.

[12]  Hongmei Yu,et al.  miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog. , 2016, Biochemical and biophysical research communications.

[13]  W. Guo,et al.  PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells , 2016, Oncotarget.

[14]  Zheng Wang,et al.  PAQR3 enhances Twist1 degradation to suppress epithelial-mesenchymal transition and metastasis of gastric cancer cells. , 2016, Carcinogenesis.

[15]  Handong Ma,et al.  MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2 , 2016, Oncotarget.

[16]  Xin Ma,et al.  miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2 , 2016, Oncotarget.

[17]  Ji-tao Wu,et al.  Relevance and Therapeutic Possibility of PTEN-Long in Renal Cell Carcinoma , 2015, PloS one.

[18]  Jun Ma,et al.  miR‐101 Acts as a Tumor Suppressor by Targeting Kruppel‐like Factor 6 in Glioblastoma Stem Cells , 2015, CNS neuroscience & therapeutics.

[19]  Y. Cheng,et al.  MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma. , 2014, American journal of cancer research.

[20]  C. Croce,et al.  MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use , 2014, Genome Biology.

[21]  L. Bing,et al.  MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression , 2014, Archives of Gynecology and Obstetrics.

[22]  M. Rydzanicz,et al.  Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications. , 2013, Cancer letters.

[23]  Zhiquan Hu,et al.  Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma. , 2013, Carcinogenesis.

[24]  M. Harrison,et al.  Novel immunotherapeutic strategies in development for renal cell carcinoma. , 2013, European urology.

[25]  Youn Wha Kim,et al.  Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker , 2012, Pathology.

[26]  A. Gerger,et al.  MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy. , 2012, Anticancer research.

[27]  Y. Nie,et al.  MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6 , 2012, Tumor Biology.

[28]  N. Dusetti,et al.  The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions. , 2010, Journal of hepatology.

[29]  V. Yang,et al.  Mammalian Krüppel-like factors in health and diseases. , 2010, Physiological reviews.

[30]  J. Bocco,et al.  Nuclear Expression of KLF6 Tumor Suppressor Factor Is Highly Associated with Overexpression of ERBB2 Oncoprotein in Ductal Breast Carcinomas , 2010, PloS one.

[31]  S. Friedman,et al.  Functional role of the KLF6 tumour suppressor gene in gastric cancer. , 2009, European journal of cancer.

[32]  Xia Li,et al.  KLF6 Induces Apoptosis in Prostate Cancer Cells through Up-regulation of ATF3* , 2008, Journal of Biological Chemistry.

[33]  M. Zhuang,et al.  Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines. , 2008, The Tohoku journal of experimental medicine.

[34]  E. Genden,et al.  KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma , 2007, International journal of cancer.

[35]  S. Friedman,et al.  In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma , 2007, Oncogene.

[36]  S. Friedman,et al.  Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6. , 2006, Blood.

[37]  S. Friedman,et al.  Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation. , 2005, Cancer research.

[38]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[39]  S. Friedman,et al.  Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. , 2004, Gastroenterology.

[40]  H. Frierson,et al.  Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. , 2003, The American journal of pathology.

[41]  R. Urrutia,et al.  Sp1- and Krüppel-like transcription factors , 2003, Genome Biology.

[42]  R. Motzer,et al.  Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  S. Friedman,et al.  KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer , 2001, Science.

[44]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[45]  Wei Gao,et al.  miR-543 promotes gastric cancer cell proliferation by targeting SIRT1. , 2016, Biochemical and biophysical research communications.

[46]  C. Porta,et al.  A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer. , 2015, European Urology.

[47]  P. Cairns.  Renal cell carcinoma. , 2010, Cancer biomarkers : section A of Disease markers.